Massive study aims to uncover cancer secrets in rare bone marrow diseases
NCT ID NCT00027274
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 8 times
Summary
This natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those who develop cancer from those who don't. The goal is to improve cancer screening and prevention for these high-risk groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify genetic and environmental factors that increase cancer risk in these families, pointing toward better screening and prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It may take many years to gather enough data, and findings may not apply to the general population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMEGAKARYOCYTIC THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Institute - Shady Grove
RECRUITINGRockville, Maryland, 20850, United States
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single drink reveal how alcohol triggers oral cancer?
- Worldwide data pool could pave the way for mitochondrial disease trials
- Mismatched donor stem cell transplant could widen treatment access for sickle cell disease
- Gene therapy aims to fix bone marrow failure in fanconi anemia
- New transplant method aims to reduce complications in bone marrow failure patients
- New MRI method could spot oral cancer early in rare disease patients